This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helander, A.
Right arrow Articles by Svennerholm, A.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helander, A.
Right arrow Articles by Svennerholm, A.-M.

 Previous Article  |  Next Article 

Infection and Immunity, September 1998, p. 4507-4510, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Antibody Responses in Humans against Coli Surface Antigen 6 of Enterotoxigenic Escherichia coli

Anna Helander,1,* Christine Wennerås,1 Firdausi Qadri,2 and Ann-Mari Svennerholm1

Department of Medical Microbiology and Immunology, Göteborg University, Göteborg, Sweden,1 and the International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh2

Received 12 November 1997/Returned for modification 21 January 1998/Accepted 17 June 1998

Enterotoxigenic Escherichia coli (ETEC) strains expressing only coli surface antigen 6 (CS6) have previously been isolated from patients with diarrhea, but the immunogenicity of CS6 has not been established in humans. We have detected CS6-specific immunoglobulin A responses in the feces and blood of patients convalescing from natural ETEC disease and of volunteers given an oral ETEC vaccine.

* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, Göteborg University, Guldhedsgatan 10A, 413 46 Göteborg, Sweden. Phone: 46 31 60 47 19. Fax: 46 31 82 69 76. E-mail: anna.helander{at}microbio.gu.se.

Infection and Immunity, September 1998, p. 4507-4510, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Qadri, F., Ahmed, T., Ahmed, F., Bhuiyan, M. S., Mostofa, M. G., Cassels, F. J., Helander, A., Svennerholm, A.-M. (2007). Mucosal and Systemic Immune Responses in Patients with Diarrhea Due to CS6-Expressing Enterotoxigenic Escherichia coli. Infect. Immun. 75: 2269-2274 [Abstract] [Full Text]  
  • Coster, T. S., Wolf, M. K., Hall, E. R., Cassels, F. J., Taylor, D. N., Liu, C. T., Trespalacios, F. C., DeLorimier, A., Angleberger, D. R., McQueen, C. E. (2007). Immune Response, Ciprofloxacin Activity, and Gender Differences after Human Experimental Challenge by Two Strains of Enterotoxigenic Escherichia coli. Infect. Immun. 75: 252-259 [Abstract] [Full Text]  
  • Guerena-Burgueno, F., Hall, E. R., Taylor, D. N., Cassels, F. J., Scott, D. A., Wolf, M. K., Roberts, Z. J., Nesterova, G. V., Alving, C. R., Glenn, G. M. (2002). Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously. Infect. Immun. 70: 1874-1880 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»